Deepak Kanojia

9PUBLICATIONS
47CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2024
MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate Designed for Enhanced Payload Delivery to c-MET-Expressing Tumor Cells.

Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh

|Apr 29, 2024
MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate Designed for Enhanced Payload Delivery to c-MET-Expressing Tumor Cells.

Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh

|Oct 04, 2023
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition.

Lauren R Begg, Adrienne M Orriols, Markella Zannikou

|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.

Crismita Dmello, Aarón Sonabend, Victor A Arrieta

|Dec 31, 2021
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer.

Alex Cordero, Matthew D Ramsey, Deepak Kanojia

|Dec 09, 2021
FKBP1A upregulation correlates with poor prognosis and increased metastatic potential of HNSCC.

Dhruti Patel, Aarsh M Dabhi, Crismita Dmello

Pageof 2

Frequent Collaborators

4 joint publications

Maciej S Lesniak

3 joint publications

Jawad Fares

2 joint publications

Federico Colombo

2 joint publications

Vijay Ramesh